Breaking News Instant updates and real-time market news.

CELG

Celgene

$99.64

1.14 (1.16%)

08:25
10/18/16
10/18
08:25
10/18/16
08:25

Celgene to hold a conference call

Management provides an update on Phase 1b data on GED-0301 in Crohn's disease on a conference call to be held on October 18 at 9 am. Webcast Link

  • 18

    Oct

  • 27

    Oct

  • 06

    Nov

CELG Celgene
$99.64

1.14 (1.16%)

10/18/16
JEFF
10/18/16
NO CHANGE
JEFF
Jefferies sees 'attractive buying opportunities' in Biotech
The Jefferies Biotechnology team sees "attractive buying opportunities" amidst the pre-election weakness. While volatility will likely continue into the election, valuation multiples are near-historic lows and policy concerns, while valid, are likely overstated, the analysts tell investors in a research note. They recommend using the weakness to buy select names ahead of a potential improvement in sentiment. Jefferies likes Gilead (GILD) and Celgene (CELG) among large-caps, The Medicines Co. (MDCO), Alkermes (ALKS) and Vertex (VRTX) among mid-caps, and Alder Biopharmaceuticals (ALDR), Cempra (CEMP), Ultragenyx (RARE) and Immunomedics (IMMU) among small-caps.
10/17/16
LEER
10/17/16
NO CHANGE
LEER
Market Perform
Celgene data suggests viable drug, says Leerink
Leerink analyst Geoffrey Porges notes that Celgene has announced top-line results from Phase 1b study of GED-301 in Crohn's Disease, and says that absent statistical analyses or a greater insight into participant performance across the study's treatment arms, or longer duration of follow-up, it is difficult to evaluate the full significance of these results. Nonetheless, the analyst believes the drug seems to have some modest efficacy which bodes positively for potential approval as a front-line agent in Crohn's Disease. He reiterates a Market Perform rating on the shares.
10/17/16
WELS
10/17/16
NO CHANGE
WELS
Celgene data better than expected, says Wells Fargo
After Celgene announced detailed results from a phase 1b study of oral mogersen in moderate-to severe Crohn's Disease, Wells Fargo says that the results "are better than expected" and leave the company's drug "favorably" positioned relative to approved biologics. The firm says that Celgene's drug "could be positioned as the first highly effective oral for Crohn's Disease," and it keeps an Outperform rating on the stock.
10/14/16
ADAM
10/14/16
NO CHANGE
Target $156
ADAM
Buy
Celgene pipeline broader and stronger than ever, says Canaccord
Canaccord analyst John Newman said Celgene's pipeline is broader and stronger than at any point in its history.He reiterated his Buy rating based on his confidence in the commercial potential for GED-0301 for Crohn's disease, ozanimod in both ulcerative colitis and multiple sclerosis, and continued growth for Otezla. Newman reiterated his $156 price target on Celgene shares.

TODAY'S FREE FLY STORIES

SBCF

Seacoast Banking

$23.70

-0.53 (-2.19%)

14:33
02/21/17
02/21
14:33
02/21/17
14:33
Conference/Events
Seacoast Banking to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FXI

iShares Trust FTSE/Xinhua China 25 Fund

$38.76

0.3 (0.78%)

14:31
02/21/17
02/21
14:31
02/21/17
14:31
Options
Notable spreads in the Largecap China ETF »

Notable spreads in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEM

Newmont Mining

$37.35

0.34 (0.92%)

, WCN

Waste Connections

$83.81

0.2099 (0.25%)

14:29
02/21/17
02/21
14:29
02/21/17
14:29
Earnings
Notable companies reporting after market close »

Notable companies…

NEM

Newmont Mining

$37.35

0.34 (0.92%)

WCN

Waste Connections

$83.81

0.2099 (0.25%)

VRSK

Verisk Analytics

$84.90

0.63 (0.75%)

NFX

Newfield Exploration

$42.51

0.69 (1.65%)

KAR

KAR Auction

$46.55

0.07 (0.15%)

XPO

XPO Logistics

$48.60

-0.62 (-1.26%)

FSLR

First Solar

$34.84

0.73 (2.14%)

TXRH

Texas Roadhouse

$48.24

0.13 (0.27%)

TEX

Terex

$32.14

0.14 (0.44%)

PZZA

Papa John's

$86.01

-0.39 (-0.45%)

WLL

Whiting Petroleum

$11.61

0.5 (4.50%)

SPN

Superior Energy

$16.64

0.215 (1.31%)

DEPO

Depomed

$16.47

-0.38 (-2.26%)

RRGB

Red Robin

$47.80

0.05 (0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 24

    Feb

  • 26

    Feb

  • 01

    Mar

  • 05

    Mar

  • 07

    Mar

  • 07

    Mar

  • 13

    Mar

  • 14

    Mar

  • 14

    Mar

  • 15

    Mar

CDE

Coeur Mining

$9.20

0.315 (3.55%)

14:26
02/21/17
02/21
14:26
02/21/17
14:26
Options
Coeur Mining call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:25
02/21/17
02/21
14:25
02/21/17
14:25
General news
Canada Retail Sales Preview »

Canada Retail Sales…

14:25
02/21/17
02/21
14:25
02/21/17
14:25
Conference/Events
Leerink specialty pharma/biotech analysts hold analyst/industry conference call »

Specialty Pharmaceuticals…

VLKAY

Volkswagen

$30.87

-0.65 (-2.06%)

, TTM

Tata Motors

$34.20

0.74 (2.21%)

14:24
02/21/17
02/21
14:24
02/21/17
14:24
Periodicals
Volkswagen, Tata Motors in advanced partnership talks, Economic Times says »

Volkswagen (VLKAY) and…

VLKAY

Volkswagen

$30.87

-0.65 (-2.06%)

TTM

Tata Motors

$34.20

0.74 (2.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QSR

Restaurant Brands

$57.56

3.66 (6.79%)

, PLKI

Popeyes

$66.12

-0.26 (-0.39%)

14:24
02/21/17
02/21
14:24
02/21/17
14:24
Periodicals
Popeyes declined rival bid from Arby's, Bloomberg reports »

Popeyes Louisiana Kitchen…

QSR

Restaurant Brands

$57.56

3.66 (6.79%)

PLKI

Popeyes

$66.12

-0.26 (-0.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 23

    Feb

  • 23

    Mar

14:21
02/21/17
02/21
14:21
02/21/17
14:21
General news
Stocks drifting near all-time best levels »

Stocks remain in positive…

$NSD

NASDAQ Market Internals

14:18
02/21/17
02/21
14:18
02/21/17
14:18
Technical Analysis
NASDAQ Market Internals summary »

Breadth is bullish across…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

14:17
02/21/17
02/21
14:17
02/21/17
14:17
Technical Analysis
NYSE Market Internals summary »

Breadth is bullish across…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBI

Pitney Bowes

$13.74

0.35 (2.61%)

14:11
02/21/17
02/21
14:11
02/21/17
14:11
Options
Bullish option flow in Pitney Bowes »

Bullish option flow in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

HD

Home Depot

$144.01

1.0148 (0.71%)

14:08
02/21/17
02/21
14:08
02/21/17
14:08
Recommendations
Home Depot analyst commentary  »

Home Depot price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 15

    Mar

EXAS

Exact Sciences

$19.91

-0.26 (-1.29%)

14:08
02/21/17
02/21
14:08
02/21/17
14:08
Upgrade
Exact Sciences rating change  »

Exact Sciences upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

AG

First Majestic

$9.86

-0.2 (-1.99%)

14:06
02/21/17
02/21
14:06
02/21/17
14:06
Options
First Majestic call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

DVA

DaVita

$68.36

1.46 (2.18%)

, CI

Cigna

$145.74

2.18 (1.52%)

14:02
02/21/17
02/21
14:02
02/21/17
14:02
Hot Stocks
HealthCare Partners, Cigna form alliance to deliver new health plans in L.A. »

HealthCare Partners, a…

DVA

DaVita

$68.36

1.46 (2.18%)

CI

Cigna

$145.74

2.18 (1.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

AJG

Arthur J. Gallagher

$56.41

-0.53 (-0.93%)

14:00
02/21/17
02/21
14:00
02/21/17
14:00
Hot Stocks
Arthur J. Gallagher acquires Kelly Financial, terms not disclosed »

Arthur J. Gallagher &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXAS

Exact Sciences

$19.91

-0.26 (-1.29%)

13:55
02/21/17
02/21
13:55
02/21/17
13:55
Recommendations
Exact Sciences analyst commentary  »

Craig-Hallum would still…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

IMPV

Imperva

$45.70

0.8 (1.78%)

, CHKP

Check Point

$101.21

0.21 (0.21%)

13:51
02/21/17
02/21
13:51
02/21/17
13:51
Periodicals
Homeland Security having problems with computer systems, Reuters reports »

Some U.S. Department of…

IMPV

Imperva

$45.70

0.8 (1.78%)

CHKP

Check Point

$101.21

0.21 (0.21%)

SYMC

Symantec

$28.80

0.33 (1.16%)

PANW

Palo Alto Networks

$154.58

-0.18 (-0.12%)

QLYS

Qualys

$35.60

1.35 (3.94%)

FFIV

F5 Networks

$143.35

0.11 (0.08%)

FTNT

Fortinet

$37.46

0.215 (0.58%)

CUDA

Barracuda

$23.93

-0.07 (-0.29%)

FEYE

FireEye

$11.83

0.48 (4.23%)

PFPT

Proofpoint

$81.84

0.31 (0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 27

    Feb

  • 28

    Feb

  • 28

    Feb

  • 02

    Mar

  • 03

    Mar

  • 05

    Mar

K

Kellogg

$74.11

1.21 (1.66%)

13:51
02/21/17
02/21
13:51
02/21/17
13:51
Options
Hefty call spread in Kellogg as shares rally »

Hefty call spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

DBD

Diebold

$29.60

-0.5 (-1.66%)

13:47
02/21/17
02/21
13:47
02/21/17
13:47
Conference/Events
Diebold to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

MNK

Mallinckrodt

$53.66

-1.0799 (-1.97%)

13:46
02/21/17
02/21
13:46
02/21/17
13:46
Options
Mallinckrodt call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

HAS

Hasbro

$98.50

0.86 (0.88%)

13:45
02/21/17
02/21
13:45
02/21/17
13:45
Conference/Events
Hasbro management to meet with Wells Fargo »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 22

    Feb

  • 22

    Feb

KFY

Korn/Ferry

$30.46

-0.1498 (-0.49%)

, GSK

GlaxoSmithKline

$41.50

0.16 (0.39%)

13:44
02/21/17
02/21
13:44
02/21/17
13:44
Hot Stocks
Korn Ferry Futurestep partners with GlaxoSmithKline over talent acquisition »

Futurestep division of…

KFY

Korn/Ferry

$30.46

-0.1498 (-0.49%)

GSK

GlaxoSmithKline

$41.50

0.16 (0.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

13:35
02/21/17
02/21
13:35
02/21/17
13:35
General news
NY Fed accepted $163.3 B in daily reverse repos »

NY Fed accepted $163.3 B…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.